+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Intragastric Balloons Market: By Balloon Type; By Geography - Forecast 2016-2021

  • ID: 4033451
  • Report
  • 144 pages
  • IndustryARC
1 of 2
Intragastric Balloons is a medical procedure which includes inserting of uninflated balloons with the help of endoscopes and then inflate the balloons in the stomach by filling it with saline solution to decrease the available stomach volume and partially filling the stomach. Intragastric balloon procedure is used in morbid obesity cases to decrease hunger and is helpful for patients who cannot lose weight by any other means and are prone to serious health problems related to obesity. As per WHO, 39% of adult population (aged 18 years and above) were overweight in 2014, and 13% were obese. Obesity has received considerable attention as a major health hazard as it leads to adverse metabolic effects such as High Blood Pressure, Diabetes, Coronary Heart Disease and Ischemic stroke. Globally, increasing obese population as a result of changing life style and increasing cases of obesity related health issues are expected to remain the prime growth drivers for intragastric balloons during the period of study.

Geographically, North America dominated the intragastric balloons market driven by world class healthcare infrastructure with technological advanced practice, higher spending, large population with obesity and related diseases and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for intragastric balloons. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the intragastric balloons market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the intragastric balloons market.

This report segments the intragastric balloons market on the basis of treatment type and regional market as follows:
Intragastric balloons market research report is classified on the basis of treatment type. Some of the major intragastric treatment types covered in this report are as follows: Endoscopic Intagastric balloon, ReShape Duo, Abalon or Balloon Pill.

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the intragastric balloons market. Some of the major companies’ profiles in detail are as follows:

Apollo Endosurgery
Helioscopie Medical Implants
Spatz FGIA Inc
Allurion technologies
Districlass Medical SA
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Intragastric balloons Market – Overview

2. Executive Summary

3. Intragastric balloons Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Intragastric balloons Market– Forces
4.1. Drivers
4.1.1. Globally increasing population of obese people
4.1.2. Preference of MSI over open surgery
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Intragastric balloons Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Intragastric balloons Market, By Treatment type
6.1. Endoscopic Intagastric balloon
6.2. ReShape Duo
6.3. Abalon

7. Intragastric balloons Market, By Geography
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Intragastric balloons Market – Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Apollo Endosurgery
9.2. Helioscopie Medical Implants
9.3. Spatz FGIA Inc
9.4. Allurion technologies
9.5. Districlass Medical SA
9.6. Endalis
9.7. Fengh Medical
9.8. Lexal Srl
9.9. Life Partners Europe
9.10. Medicone
9.11. Medsil
9.12. Obalon Therapeutics
9.13. Phagia Technologies
9.14. PlenSat
9.15. ReShape Medical.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of Expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 2